Fig. 2: ELISA validation of elevated urinary proteins in African-American and Caucasian lupus nephritis patients. | Nature Communications

Fig. 2: ELISA validation of elevated urinary proteins in African-American and Caucasian lupus nephritis patients.

From: Comprehensive aptamer-based screening identifies a spectrum of urinary biomarkers of lupus nephritis across ethnicities

Fig. 2

Plotted are ELISA-validation results for 12 urine proteins in African-American and Caucasian subjects. Each protein was tested using the following sample group: 27 active SLE samples (14 African-American, 13 Caucasian), 47 inactive SLE samples (19 African-American, 28 Caucasian), and 21 healthy controls (14 African-American, 7 Caucasian). The plots show the mean concentration in urine for each disease group after normalizing against urinary creatinine. *p < 0.05, **p < 0.01, and ***p < 0.001, as determined using Mann–Whitney U-test. Further details regarding these proteins are included in Supplementary Data. Source data are provided as a Source Data file.

Back to article page